Overview
Clinical Meaning
Portal hypertension in cirrhosis results from increased intrahepatic resistance (structural: fibrosis, nodular distortion; dynamic: stellate cell contraction from decreased nitr...
WHNP
WHNP
Portal hypertension in cirrhosis results from increased intrahepatic resistance (structural: fibrosis, nodular distortion; dynamic: stellate cell contraction from decreased nitric oxide and increased endothelin-1) and increased portal blood flow (splanchnic vasodilation from excessive nitric oxide production in the mesenteric circulation). When the hepatic venous pressure gradient (HVPG) exceeds 10 mmHg, portosystemic collaterals develop at sites of portal-systemic anastomosis: esophageal varices (left gastric vein → esophageal veins), caput medusae (paraumbilical veins), hemorrhoids (superior → inferior rectal veins), and retroperitoneal shunts. Splanchnic vasodilation reduces effective arterial blood volume, triggering RAAS activation, sympathetic nervous system stimulation, and ADH release, causing renal sodium and water retention (ascites) and ultimately hepatorenal syndrome.
Unlock full lesson + practice questions
4 more sections with scenarios, priorities, and review drills.
Next study step
Finish the lesson first, then choose a focused activity to apply what you just reviewed.
Continue studying
Sign in to save progress on this lesson.
Unlock the interactive lesson quiz with a plan that includes this WHNP pathway. You can still explore topic-filtered questions from the bank hubs below.